Stock Ratings / Health Care / AKAN / news

IMCC (64) NAII (34) BON (45) MTEX (33) ⌘ Pro Terminal →

Why AKAN Stock surged +2.80% Today — RQD Quant Desk Flash

Q: Is AKAN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Akanda Corp. (NASDAQ: AKAN) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $1.10 (+2.80% 1D, market cap $2.6M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, AKAN ranks #299 in composite RQD confidence.

Q: How does AKAN compare to IMCC and NAII in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), AKAN carries a Roarable D+ (54/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, IMCC (IM Cannabis Corp.) holds a C grade (64/100 RQD, P/E N/A, ROIC —, cap $1.5M) and NAII (Natural Alternatives International Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -10.8%, cap $6.9M). Among the 5-stock peer group, AKAN leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for AKAN?

For Akanda Corp. (AKAN), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #299 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is AKAN trading relative to its 50-day, 200-day, and 52-week technical levels?

AKAN last traded at $1.10 (+2.80% on volume of 77,001 shares), positioning the stock -56.00% below its 50-day simple moving average ($2.50) and -86.87% below its 200-day simple moving average ($8.38). Across its 52-week range of $1.00 to $78.90, AKAN sits at the 0.1% percentile with a 14-day RSI of 24.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $1.24).

Q: Why is AKAN stock moving today?

Why AKAN Stock surged +2.80% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.

$1.10 +2.80% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Akanda Corp. (AKAN) carries a Roarable Rating of D+ (Sell) with 54/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $2.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-1.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for AKAN)Realized 20D OHLCV Swing Band: ±12.5%

AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →

Why AKAN Stock surged +2.80% Today — RQD Quant Desk Flash

Akanda Corp. (AKAN) surged +2.80% to $1.10, trading at 2% of its 52-week range ($1 – $78.9). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.

▸Technical Tape: Trading at 2% of its 52-week range ($1 – $78.9) with RSI-14 at 24.1 (OVERSOLD (<32)).
▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.10 (no active unusual options sweep snapshot on file).
▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $73557 annual free cash flow.

Live AKAN Headlines & Catalysts

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AKAN)

✓Walkthrough of AKAN's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

AKAN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -97.75%▲ RESISTANCE BREAKOUT

2026-10-30O $1.02H $1.10L $1.01C $1.10VOL 44.9K

RES: $-4.44SUP: $-1.15SMA50: $2.50SMA200: $8.38

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AKAN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 AKAN Butterfly Map → + Track AKAN →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AKAN today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for AKAN. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for AKAN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AKAN)

Health Care Rank #299 of 1016 ⚔️ IMCC vs AKAN Full Matrix →

1. Head-to-Head Health Care Peer Comparison (AKAN vs. IMCC, NAII, BON, MTEX)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Akanda Corp. (AKAN) ranks #299 by composite RQD confidence (54/100, grade D+) and #984 by equity capitalization ($2.6M). Within this direct 5-issuer industry benchmark cohort, AKAN leads on earnings valuation at N/A trailing P/E, while NAII leads on capital efficiency and profitability with -10.8% ROIC and 7.2% gross margin. IMCC currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with AKAN at 54/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
AKAN ACTIVE Akanda Corp.	D+	54/100	—	—	—	+2.80%	$2.6M	Benchmark Subject
IMCC IM Cannabis Corp.	C	64/100	—	—	—	+3.53%	$1.5M	/imcc-vs-akan →
NAII Natural Alternatives International Inc.	E	34/100	—	7.2%	-10.8%	-4.31%	$6.9M	/naii-vs-akan →
BON Bon Natural Life Limited (Class A)	D	45/100	—	20.8%	—	-0.01%	$9.2M	/bon-vs-akan →
MTEX Mannatech Incorporated	E	33/100	—	74.9%	-35.0%	-2.23%	$16.1M	/mtex-vs-akan →

2. AKAN Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Akanda Corp. (AKAN) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $2.6M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. AKAN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AKAN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Akanda Corp. (NASDAQ: AKAN) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $1.10 (+2.80% 1D, market cap $2.6M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, AKAN ranks #299 in composite RQD confidence.

How does AKAN compare to IMCC and NAII in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), AKAN carries a Roarable D+ (54/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, IMCC (IM Cannabis Corp.) holds a C grade (64/100 RQD, P/E N/A, ROIC —, cap $1.5M) and NAII (Natural Alternatives International Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -10.8%, cap $6.9M). Among the 5-stock peer group, AKAN leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AKAN?

For Akanda Corp. (AKAN), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #299 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AKAN trading relative to its 50-day, 200-day, and 52-week technical levels?

AKAN last traded at $1.10 (+2.80% on volume of 77,001 shares), positioning the stock -56.00% below its 50-day simple moving average ($2.50) and -86.87% below its 200-day simple moving average ($8.38). Across its 52-week range of $1.00 to $78.90, AKAN sits at the 0.1% percentile with a 14-day RSI of 24.1 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $1.24).

AKAN Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Why is AKAN stock moving today?

Why AKAN Stock surged +2.80% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.

Direct Sub-Reports: AKAN RQD Cockpit AKAN 12M Forecast AKAN Earnings & Move AKAN Dividends & DRIP AKAN Insiders & 13F AKAN Whale Options AKAN Profit Sankey AKAN News & Why